-

ROBINHOOD INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Robinhood Markets, Inc. - HOOD

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Robinhood Markets, Inc. (NasdaqGS: HOOD).

During its July 2021 Initial Public Offering (IPO), the Company touted its significant growth, quality execution, high security standards, and commitment to providing users with a highly accessible and safe trading experience. In October 2021, the Company disclosed a range of negative financial and operational results, covering the same period that its IPO was held, including declines in total net revenue, monthly active users, funded accounts, assets under custody, and average revenue per user, among other things. Then, on November 8, 2021, the Company disclosed that it had experienced a “data security incident” on November 3rd in which hackers were able to gain access to certain personal information of roughly 7 million users.

KSF’s investigation is focusing on whether Robinhood’s officers and/or directors breached their fiduciary duties to Robinhood’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Robinhood shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-hood/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Kahn Swick & Foti, LLC

NASDAQ:HOOD

Release Versions

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

CarMax Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CarMax, Inc. - KMX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CarMax, Inc. (NYSE: KMX) (“CarMax” or the “Company”).On September 25, 2025, the Company announced its second quarter Fiscal Year 2026 financial results, disclosing, among other things, that retail unit sales had decreased 5.4%, comparable store unit sales had decreased 6.3...

Equitable Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Equitable Holdings, Inc. - EQH

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Equitable Holdings, Inc. (NYSE: EQH) and Corebridge Financial, Inc. (NYSE: CRBG). Under the terms of the agreement, each outstanding share of Equitable common stock will be exchanged for the right to receive 1.55516 shares of the new parent company’s common stock, and upon completion of the proposed transact...

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,...
Back to Newsroom